To Evaluate the Treatment Effect of an Anti-Infective Agent for Complicated Infections (0826-053)

NCT00397956 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Sepsis

Interventions

DRUG: MK0826, ertapenem sodium / Duration of Treatment: 14 Days

Sponsor

Merck Sharp & Dohme LLC